RecruitingPhase 3NCT06119581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerSponsor: Eli Lilly and CompanyBurlington, VT · +86 more sites
RecruitingPhase 2NCT05642572Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)Sponsor: SWOG Cancer Research NetworkBerlin Corners, VT · Burlington, VT · +451 more sites
RecruitingPhase 2 / Phase 3NCT03851445Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerSponsor: SWOG Cancer Research NetworkBerlin Corners, VT · Burlington, VT · +1226 more sites
RecruitingNot applicableNCT06432972Accelerated Pulmonary Rehabilitation in the Preoperative PeriodSponsor: University of VermontBurlington, VT